Literature DB >> 6197869

Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation.

G Gahrton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197869     DOI: 10.1016/s0065-230x(08)60682-x

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  4 in total

1.  Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.

Authors:  D Samid; D M Flessate; R M Friedman
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

Review 2.  Clinical pharmacokinetics of cytarabine formulations.

Authors:  Akinobu Hamada; Takeo Kawaguchi; Masahiro Nakano
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.

Authors:  D H Horber; H Schott; R A Schwendener
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Synthesis and in vitro cytostatic activity of new beta-D-arabino furan[1',2':4,5]oxazolo- and arabino-pyrimidinone derivatives.

Authors:  Jean-Jacques Bosc; Laurent Latxague; Jean-Michel Léger; Jan Balzarini; Isabelle Forfar; Christian Jarry; Jean Guillon
Journal:  Eur J Med Chem       Date:  2009-10-29       Impact factor: 6.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.